Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
advertise
Legal Help
login/register
You are here
Home
»
companies
» BPX-501
BPX-501
Bellicum Pharmaceuticals Rakes in $69 Million - Closes Public Offering
Bellicum
BPX-501
Flag link:
Bellicum Shares Up After Clinical Hold lifted on BPX-501
Bellicum Shares Up After Clinical Hold lifted on BPX-501
CP Wire
Bellicum
BPX-501
FDA
clinical trials
Flag link:
Bellicum Shares Up After Clinical Hold lifted on BPX-501
Bellicum
BPX-501
Flag link:
Bellicum Pharmaceuticals Faces Clinical Hold After Three Patients Suffer Brain Damage
Bellicum Pharmaceuticals Faces Clinical Hold After Three Patients Suffer Brain Damage
Xtalks
Bellicum
clinical trials
BPX-501
hematologic cancers
Flag link:
9 Notable Biotechs Presenting At This Year's ASH Meeting
9 Notable Biotechs Presenting At This Year's ASH Meeting
Yahoo
ASH
Bluebird Bio
LentiGlobin
Ziopharm Oncology
Bellicum
BPX-501
Spark Therapeutics
SPK-8011
Biomarin
BMN 270
Juno Therapeutics
CAR-T
Novartis
Geron
imetelstat
Immunogen
IMGN632
IMGN779
Flag link:
Bellicum Therapy Reduces Risk from Mismatched Stem Cell Transplants
Bellicum Therapy Reduces Risk from Mismatched Stem Cell Transplants
TheStreet.com
Bellicum
stem cells
BPX-501
t cell therapy
Flag link:
